242 related articles for article (PubMed ID: 20526797)
1. Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery.
Zachenhofer I; Donat M; Oberndorfer S; Roessler K
J Neurooncol; 2011 Jan; 101(1):101-6. PubMed ID: 20526797
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.
Lee YJ; Kim T; Bae SH; Kim YH; Han JH; Yun CH; Kim CY
CNS Drugs; 2013 Sep; 27(9):753-9. PubMed ID: 23921717
[TBL] [Abstract][Full Text] [Related]
3. The risk of hypotension and seizures in patients receiving prophylactic anti-epileptic drugs for supratentorial craniotomy.
Höhne J; Schebesch KM; Ott C; Brawanski A; Lange M
J Neurosurg Sci; 2018 Aug; 62(4):418-422. PubMed ID: 27854111
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Milligan TA; Hurwitz S; Bromfield EB
Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study.
Iuchi T; Kuwabara K; Matsumoto M; Kawasaki K; Hasegawa Y; Sakaida T
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1158-62. PubMed ID: 25511789
[TBL] [Abstract][Full Text] [Related]
6. Perioperative levetiracetam for seizure prophylaxis in seizure-naive brain tumor patients with focus on neurocognitive functioning.
Konrath E; Marhold F; Kindler W; Scheichel F; Popadic B; Blauensteiner K; Calabek B; Freydl E; Weber M; Ristl R; Hainz K; Sherif C; Oberndorfer S
BMC Neurol; 2022 Jul; 22(1):250. PubMed ID: 35804291
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic antiepileptic treatment with levetiracetam for patients undergoing supratentorial brain tumor surgery: a two-center matched cohort study.
Kamenova M; Stein M; Ram Z; Grossman R; Guzman R; Mariani L; Roth J; Soleman J
Neurosurg Rev; 2020 Apr; 43(2):709-718. PubMed ID: 31098789
[TBL] [Abstract][Full Text] [Related]
8. Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.
Bähr O; Hermisson M; Rona S; Rieger J; Nussbaum S; Körtvelyessy P; Franz K; Tatagiba M; Seifert V; Weller M; Steinbach JP
Acta Neurochir (Wien); 2012 Feb; 154(2):229-35; discussion 235. PubMed ID: 21909835
[TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.
Newton HB; Dalton J; Goldlust S; Pearl D
J Neurooncol; 2007 Sep; 84(3):293-6. PubMed ID: 17431542
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of levetiracetam for patients with supratentorial brain tumors.
Yuan Y; Peizhi Z; Maling G; Wu L; Yunhe M; Xiang W; Qing M; Yanhui L; Ruofei L; Jiewen L
J Clin Neurosci; 2015 Aug; 22(8):1227-31. PubMed ID: 26051171
[TBL] [Abstract][Full Text] [Related]
12. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
Abou-Khalil B; Hemdal P; Privitera MD
Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.
Pourzitaki C; Tsaousi G; Apostolidou E; Karakoulas K; Kouvelas D; Amaniti E
Br J Clin Pharmacol; 2016 Jul; 82(1):315-25. PubMed ID: 26945547
[TBL] [Abstract][Full Text] [Related]
14. A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas.
Garbossa D; Panciani PP; Angeleri R; Battaglia L; Tartara F; Ajello M; Agnoletti A; Versari P; Ducati A; Fontanella M; Spena G
Neurol India; 2013; 61(2):131-7. PubMed ID: 23644311
[TBL] [Abstract][Full Text] [Related]
15. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
[TBL] [Abstract][Full Text] [Related]
16. Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine.
Mauro AM; Bomprezzi C; Morresi S; Provinciali L; Formica F; Iacoangeli M; Scerrati M
J Neurooncol; 2007 Feb; 81(3):279-85. PubMed ID: 16944312
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam therapy in patients with brain tumour and epilepsy.
Maschio M; Albani F; Baruzzi A; Zarabla A; Dinapoli L; Pace A; Pompili A; Carapella CM; Occhipinti E; Jandolo B
J Neurooncol; 2006 Oct; 80(1):97-100. PubMed ID: 16685465
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Levetiracetam for Seizure Control After Cranioplasty: A Multicenter Prospective Controlled Study.
Liang S; Ding P; Zhang S; Zhang J; Zhang J; Wu Y
World Neurosurg; 2017 Jun; 102():284-292. PubMed ID: 28315449
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam monotherapy for elderly patients with epilepsy.
Alsaadi TM; Koopmans S; Apperson M; Farias S
Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients.
Newton HB; Goldlust SA; Pearl D
J Neurooncol; 2006 May; 78(1):99-102. PubMed ID: 16541329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
